Özkahya M - Search Results

1

Impedance ratio: a novel marker and a powerful predictor of mortality in hemodialysis patients.

Demirci C, Aşcı G, Demirci MS, Özkahya M, Töz H, Duman S, Sipahi S, Erten S, Tanrısev M, Ok E. Demirci C, et al. Among authors: ozkahya m. Int Urol Nephrol. 2016 Jul;48(7):1155-62. doi: 10.1007/s11255-016-1292-1. Epub 2016 Apr 19. Int Urol Nephrol. 2016. PMID: 27093965

2

The efficiency of fractionated parenteral iron treatment in CAPD patients.

Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A. Akcicek F, et al. Among authors: ozkahya m. Adv Perit Dial. 1997;13:109-12. Adv Perit Dial. 1997. PMID: 9360661 Clinical Trial.

3

Disappearance of mitral and tricuspid regurgitation in haemodialysis patients after ultrafiltration.

Cirit M, Ozkahya M, Cinar CS, Ok E, Aydin S, Akçiçek F, Dorhout Mees EJ. Cirit M, et al. Among authors: ozkahya m. Nephrol Dial Transplant. 1998 Feb;13(2):389-92. doi: 10.1093/oxfordjournals.ndt.a027835. Nephrol Dial Transplant. 1998. PMID: 9509451

4

Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs.

Ozkahya M, Ok E, Cirit M, Aydin S, Akçiçek F, Başçi A, Dorhout Mees EJ. Ozkahya M, et al. Nephrol Dial Transplant. 1998 Jun;13(6):1489-93. doi: 10.1093/ndt/13.6.1489. Nephrol Dial Transplant. 1998. PMID: 9641180

5

Hypervolemia in dialysis patients--Doppler echocardiography studies.

Ozerkan F, Töz H, Ozkahya M, Cirit M, Soydaş CC. Ozerkan F, et al. Among authors: ozkahya m. Nephrol Dial Transplant. 1998 Aug;13(8):2151-3. doi: 10.1093/oxfordjournals.ndt.a027905. Nephrol Dial Transplant. 1998. PMID: 9719190 No abstract available.

6

Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor.

Ozkahya M, Töz H, Unsal A, Ozerkan F, Asci G, Gürgün C, Akçiçek F, Mees EJ. Ozkahya M, et al. Am J Kidney Dis. 1999 Aug;34(2):218-21. doi: 10.1016/s0272-6386(99)70346-x. Am J Kidney Dis. 1999. PMID: 10430965

7

Long-term evolution of cardiomyopathy in dialysis patients.

Töz H, Ozkahya M, Dorhout Mees EJ. Töz H, et al. Among authors: ozkahya m. Kidney Int. 1999 Jul;56(1):350-1. doi: 10.1038/sj.ki.4495560. Kidney Int. 1999. PMID: 10438253 Free article. No abstract available.

8

Tuberculosis in renal transplant recipients.

Sayiner A, Ece T, Duman S, Yildiz A, Ozkahya M, Kiliçaslan Z, Tokat Y. Sayiner A, et al. Among authors: ozkahya m. Transplantation. 1999 Nov 15;68(9):1268-71. doi: 10.1097/00007890-199911150-00009. Transplantation. 1999. PMID: 10573062

9

Strict volume control normalizes hypertension in peritoneal dialysis patients.

Günal AI, Duman S, Ozkahya M, Töz H, Asçi G, Akçiçek F, Basçi A. Günal AI, et al. Among authors: ozkahya m. Am J Kidney Dis. 2001 Mar;37(3):588-93. Am J Kidney Dis. 2001. PMID: 11228184

10

Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?

Duman S, Günal AI, Sen S, Asçi G, Ozkahya M, Terzioglu E, Akçiçek F, Atabay G. Duman S, et al. Among authors: ozkahya m. Perit Dial Int. 2001 Mar-Apr;21(2):219-24. Perit Dial Int. 2001. PMID: 11330572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters